Mark Topazian

19.1k citations
288 papers · 10.7k · 3 hit papers · h-index 52

Impact in

  • Rheumatology top 0.1%
    • IgG4-Related and Inflammatory Diseases
  • Surgery top 0.1%
    • Pancreatitis Pathology and Treatment
    • Gastrointestinal disorders and treatments
    • Esophageal and GI Pathology
    • Pediatric Hepatobiliary Diseases and Treatments

Papers in

    • Pancreatitis Pathology and Treatment 65
    • Esophageal and GI Pathology 36
    • Gastrointestinal disorders and treatments 23
    • Pediatric Hepatobiliary Diseases and Treatments 14
    • Bariatric Surgery and Outcomes 13
    • Gallbladder and Bile Duct Disorders 55

Mark Topazian

275 papers receiving 10.4k citations

Mark Topazian's Hit Papers

Rituximab for IgG4-related disease: a prospective, open-label trial 2015 · 464 citations
4640+6+13Years since publication200400600

Peers

Mark Topazian
Comparison fields: 5 of 119
  • Rheumatology 2.7k
  • Surgery 6.4k
  • Oncology 3.0k
  • Pulmonary and Respiratory Medicine 2.7k
  • Gastroenterology 306
Replace Ian C. Lavery with:
Ian C. Lavery United States
Bruce G. Wolff United States
Anthony J. Senagore United States
Neil Hyman United States
Roger R. Dozois United States
R. Lambert Canada
J C Goligher United Kingdom
Pierre A. Clavien Switzerland
Stuart Sherman United States
Robert D. Madoff United States
Mark Topazian relative to Ian C. Lavery United States Ian C. Lavery's profile →
Citations per field
00.5×4.7×
Ian C. Lavery · 1×
Citations per year

Countries citing papers authored by Mark Topazian

Since Specialization
Citations

This map shows the geographic impact of Mark Topazian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Topazian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Topazian more than expected).

Fields of papers citing papers by Mark Topazian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Topazian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Topazian. The network helps show where Mark Topazian may publish in the future.

Co-authors

The 25 scholars most cited alongside Mark Topazian, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mark Topazian Line = papers co-authored together Mark Topazian links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 288 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Diagnosis of Autoimmune Pancreatitis: The Mayo Clinic Experience
Hit paper breakdown →
2006692
2
Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy
Hit paper breakdown →
2008606
3
Rituximab for IgG4-related disease: a prospective, open-label trial
Hit paper breakdown →
2015464
4 2007396
5 2010297
6 2012268
7 2015206
8 2007204
9 2011202
10 2018189
11 2009155
12 2017154
13 2007152
14 2007151
15 2016138
16 2008135
17 2012133
18 2009131
19 2010125
20 2006123

About Mark Topazian

Mark Topazian is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Epidemiology and Rheumatology, having authored 288 papers that have together received 10.7k indexed citations. Recurring topics across this work include Pancreatitis Pathology and Treatment (65 papers), Pancreatic and Hepatic Oncology Research (61 papers), Gallbladder and Bile Duct Disorders (55 papers), Esophageal and GI Pathology (36 papers), Gastrointestinal disorders and treatments (23 papers), IgG4-Related and Inflammatory Diseases (14 papers), Pediatric Hepatobiliary Diseases and Treatments (14 papers) and Bariatric Surgery and Outcomes (13 papers). The work is most often cited by research in Rheumatology (2.7k citations), Surgery (6.4k citations), Oncology (3.0k citations), Pulmonary and Respiratory Medicine (2.7k citations) and Gastroenterology (306 citations). Mark Topazian has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Suresh T. Chari, Bret T. Petersen, Jonathan E. Clain, Randall K. Pearson, Thomas C. Smyrk, Naoki Takahashi, Todd H. Baron, Michael J. Levy, Santhi Swaroop Vege and Michael J. Levy. Their work appears in journals such as Gastrointestinal Endoscopy, Clinical Gastroenterology and Hepatology, Gastroenterology, The American Journal of Gastroenterology and Endoscopy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact